ACL Reconstruction Procedures Market Size Report, 2022-2030
The global ACL Reconstruction Procedures market gathered revenue around USD 7.2 billion in 2021 and market is set to grow USD 11.0 billion by the end of 2030 and is estimated to expand at a modest CAGR of 5.1% during the prediction period 2022 to 2030.
Growth Factors:
Anterior cruciate ligament (ACL) reconstruction procedure is a surgery used for replacement or repair of torn anterior cruciate ligament caused due to sports injuries. ACL is an important soft tissue structure present in the middle of the knee that connects femur to the tibia in the knee. ACL reconstruction surgery procedure involves replacement of torn ligament with tissue graft, which is similar to ACL.
Competitive athletes are at high risk of ACL injuries, which drives the demand for ACL reconstruction procedures. The growth of the global market can be attributed to increase in awareness about sports injuries and emphasis on the treatment of orthopedic disorders. This fuels the demand for advanced ACL reconstructive procedures across the globe.
Report Scope of the ACL Reconstruction Procedures Market
|
Report Coverage |
Details |
|
Market Size |
US$ 11.0 Billion by 2030 |
|
Growth Rate |
CAGR of 5.1% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Type, Fixation Type, End-user and Region, |
|
Companies Mentioned |
Zimmer Biomet Holdings, Inc., Stryker Corporation, Johnson & Johnson Services, Inc., Medtronic, DJO, LLC, Arthrex, Inc., Citieffe s.r.l., CONMED Corporation, MEIRA Corporation, Miach Orthopaedics, Smith & Nephew plc, RTI Surgical, and Tissue Regenix Group. |
ACL Reconstruction Procedures Market: Overview
Key Industry Events to Propel ACL Reconstruction Procedures Market
Various strategies adopted by prominent players such as launch of new products, merger & acquisition, and alliances with other companies are likely to propel the global ACL reconstruction procedures market during the forecast period. These players opt for various strategies such as geographic expansion, expansion of new product portfolio in developing countries, and strong distribution network in the developing countries. These factors are anticipated to boost the growth of the global ACL reconstruction procedures market. In June 2021, Colfax, the parent company of DJO LLC, entered into a definitive agreement to expand DJO’s successful reconstructive business and acquire Mathys AG Bettlach, a Switzerland-based company that develops and distributes innovative products for artificial joint replacement, synthetic bone graft solutions, and sports medicine.
In September 2021, Stryker Corporation completed the acquisition of Wright Medical Group NV, a medical device company, which focuses on extremities and biologics. This acquisition provides the company significant opportunities in providing innovative solutions to the patients.
ACL Reconstruction Procedures Market: Segmentation
ACL Reconstruction Procedures Market: Prominent Regions
In terms of region, the global ACL reconstruction procedures market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global ACL reconstruction procedures market in 2020, followed by Europe and Asia Pacific. Product launches by market players such as Zimmer Biomet, increase in the number of FDA approvals and patent grants, and rise in demand for ACL reconstruction procedures are anticipated to drive the market in North America during the forecast period. Increase in number of arthoscopy procedures in the U.S., surge in burden of patients suffering from sports injuries, rise in demand for health care products, and increase in health care spending are factors anticipated to propel the ACL reconstruction procedures market in the region. The market in North America is driven by increase in the number of Food and Drug Administration (FDA) approvals for tissue meshes and launch of fixation devices by market players.
The ACL reconstruction procedures market in Asia Pacific is expected to expand at a higher CAGR from 2022 to 2030 attributable to growing medical tourism, increase in incidence of sports injuries, technological advancements, rise in the number of orthopedic procedures, and surge in healthcare expenditure. Launch of new products in China and Japan and rigorous marketing campaigns adopted by leading players in the region to gain competitive advantage are likely to fuel the growth of the market in Asia Pacific during the forecast period.
Some of the prominent players in the ACL Reconstruction Procedures Market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in ACL Reconstruction Procedures Market Study:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global ACL Reconstruction Procedures Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global ACL Reconstruction Procedures Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
5.2. Technological Advancements
5.3. Key Industry Events
5.4. Regulatory Scenario
5.5. Overview of ACL Reconstruction Surgeries
5.6. Overview of Orthopedic Injuries and Disease prevalence across globe
6. Global ACL Reconstruction Procedures Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
6.3.1. Extra-articular
6.3.2. Intra-articular
6.3.2.1. Patellar Tendon Autograft
6.3.2.2. Hamstring Tendon Autograft
6.3.2.3. Quadriceps Tendon Autograft
6.3.2.4. Others
6.4. Global ACL Reconstruction Procedures Market Attractiveness Analysis, by Type
7. Global ACL Reconstruction Procedures Market Analysis and Forecast, by Fixation Type, 2017-2031
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
7.3.1. Femoral
7.3.2. Tibial
7.4. Global ACL Reconstruction Procedures Market Attractiveness Analysis, by Fixation Type
8. Global ACL Reconstruction Procedures Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Orthopedic Centers
8.3.3. Others
8.4. Global ACL Reconstruction Procedures Market Attractiveness Analysis, by End-user
9. Global ACL Reconstruction Procedures Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global ACL Reconstruction Procedures Market Attractiveness Analysis, by Region
10. North America ACL Reconstruction Procedures Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
10.2.1. Extra-articular
10.2.2. Intra-articular
10.2.2.1. Patellar Tendon Autograft
10.2.2.2. Hamstring Tendon Autograft
10.2.2.3. Quadriceps Tendon Autograft
10.2.2.4. Others
10.3. North America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
10.3.1. Femoral
10.3.2. Tibial
10.4. North America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Orthopedic Centers
10.4.3. Others
10.5. North America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
11. Europe ACL Reconstruction Procedures Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
11.2.1. Extra-articular
11.2.2. Intra-articular
11.2.2.1. Patellar Tendon Autograft
11.2.2.2. Hamstring Tendon Autograft
11.2.2.3. Quadriceps Tendon Autograft
11.2.2.4. Others
11.3. Europe ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
11.3.1. Femoral
11.3.2. Tibial
11.4. Europe ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Orthopedic Centers
11.4.3. Others
11.5. Europe ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
12. Asia Pacific ACL Reconstruction Procedures Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
12.2.1. Extra-articular
12.2.2. Intra-articular
12.2.2.1. Patellar Tendon Autograft
12.2.2.2. Hamstring Tendon Autograft
12.2.2.3. Quadriceps Tendon Autograft
12.2.2.4. Others
12.3. Asia Pacific ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
12.3.1. Femoral
12.3.2. Tibial
12.4. Asia Pacific ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Orthopedic Centers
12.4.3. Others
12.5. Asia Pacific ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
13. Latin America ACL Reconstruction Procedures Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
13.2.1. Extra-articular
13.2.2. Intra-articular
13.2.2.1. Patellar Tendon Autograft
13.2.2.2. Hamstring Tendon Autograft
13.2.2.3. Quadriceps Tendon Autograft
13.2.2.4. Others
13.3. Latin America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
13.3.1. Femoral
13.3.2. Tibial
13.4. Latin America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Orthopedic Centers
13.4.3. Others
13.5. Latin America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
14. Middle East & Africa ACL Reconstruction Procedures Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
14.2.1. Extra-articular
14.2.2. Intra-articular
14.2.2.1. Patellar Tendon Autograft
14.2.2.2. Hamstring Tendon Autograft
14.2.2.3. Quadriceps Tendon Autograft
14.2.2.4. Others
14.3. Middle East & Africa ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
14.3.1. Femoral
14.3.2. Tibial
14.4. Middle East & Africa ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Orthopedic Centers
14.4.3. Others
14.5. Middle East & Africa ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
15. Competitive Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Arthrex, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Strategic Overview
15.3.1.4. SWOT Analysis
15.3.2. CITIEFFE S.R.L.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Strategic Overview
15.3.2.4. SWOT Analysis
15.3.3. CONMED Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. DJO Global, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Strategic Overview
15.3.4.4. SWOT Analysis
15.3.5. Johnson & Johnson Services, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Medtronic
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Miach Orthopaedics
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Strategic Overview
15.3.7.4. SWOT Analysis
15.3.8. Meira Corporation
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Strategic Overview
15.3.8.4. SWOT Analysis
15.3.9. RTI Surgical
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Strategic Overview
15.3.9.4. SWOT Analysis
15.3.10. Smith+Nephew
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. Strategic Overview
15.3.10.5. SWOT Analysis
15.3.11. Stryker Corporation
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. Strategic Overview
15.3.11.5. SWOT Analysis
15.3.12. Tissue Regenix Group
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Strategic Overview
15.3.12.4. SWOT Analysis
15.3.13. Zimmer Biomet Holdings, Inc.
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. Financial Overview
15.3.13.4. Strategic Overview
15.3.13.5. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers